Skip to main content
Log in

Cytochrome P450 4F2 Polymorphism in Patients with Liver Cirrhosis

  • Biophysics and Biochemistry
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

1297C/T polymorphism of CYP4F2 gene was studied in 108 patients with chronic liver diseases. No significant correlation with predisposition to rapid liver cirrhosis was revealed without consideration for cirrhosis etiology (OR = 0.93, 95% CI = 0.28-2.99, p = 0.885). In patients with viral cirrhosis, a tendency to association of 1297T allele genotypes with rapid cirrhosis development was found (OR = 6.0, 95% CI = 0.28-382.64, p = 0.222). At the same time, CYP4F2 1297T allele was associated with mild (Child–Pugh class A-B) cirrhosis (OR = 2.9, p = 0.044).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. V. T. Ivashkin, D. L. Nepomnyashchikh, S. V. Aidagulova, et al., Ros. Zhurn. Gastroenterol. Gepatol. Koloproktol., No. 2, 20–29 (2009).

  2. D. L. Nepomnyashchikh,V. A. Vavilin, S. V. Aidagulova, et al., Bull. Exp. Biol. Med., 152, No. 5, 633–636 (2011).

    Article  Google Scholar 

  3. S. A. Bardowell, D. E. Stec, and R. S. Parker, J. Nutr., 140, No. 11, 1901–1906 (2010).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. S. Fishman, Y. Lurie, H. Peretz, et al., Liver Int., 26, No. 3, 279–284 (2006).

    Article  CAS  PubMed  Google Scholar 

  5. J. P. Hardwick, D. Osei-Hyiaman, H. Wiland, et al., PPAR Res., 2009 (2009). doi:10.1155/2009/952734.

  6. J. P. Hardwick, Biochem. Pharmacol., 75, No. 12, 2263–2275 (2008).

    Article  CAS  PubMed  Google Scholar 

  7. S. J. Karpen and M. Trauner, J. Hepatol., 52, No. 3, 455–462 (2010).

    Article  PubMed  Google Scholar 

  8. A. Mallat, and S. Lotersztajn, Am. J. Physiol. Gastrointest. Liver Physiol., 294, No. 1, G9–G12 (2008).

    Article  CAS  PubMed  Google Scholar 

  9. A. Mallat, F. Teixeira-Clerc, V. Deveaux, et al., Br. J. Pharmacol., 163, No. 7, 1432–1440 (2011).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. C. J. Marek, K. Wallace, E. Durward, et al., Comp. Hepatol., 8, Pt. 1 (2009). doi: 10.1186/1476-5926-8-1.

  11. M. Pratt-Hyatt, H. Zhang, N. T. Snider, and P. F. Hollenberg, Drug Metab. Dispos., 38, No. 11, 2075–2082 (2010).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. N. T. Snider, A. M. Kornilov, U. M. Kent, and P. F. Hollenberg, J. Pharmacol. Exp. Ther., 321, No. 2, 590–597 (2007).

    Article  CAS  PubMed  Google Scholar 

  13. N. T. Snider, J. A. Nast, L. A. Tesmer, and P. F. Hollenberg, Mol. Pharmacol., 75, No. 4, 965–972 (2009).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. D. E. Stec, R. J. Roman, A. Flasch, and M. J. Rieder, Physiol. Genomics., 30, No. 1, 74–81 (2007).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V. A. Vavilin.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 156, No. 8, pp. 144-148, August, 2013

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vavilin, V.A., Nepomnyashchikh, D.L., Shchepotina, E.G. et al. Cytochrome P450 4F2 Polymorphism in Patients with Liver Cirrhosis. Bull Exp Biol Med 156, 181–184 (2013). https://doi.org/10.1007/s10517-013-2305-z

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-013-2305-z

Key Words

Navigation